Literature DB >> 1347914

Modulation of normal erythroid differentiation by the endogenous thyroid hormone and retinoic acid receptors: a possible target for v-erbA oncogene action.

C Schroeder1, L Gibson, M Zenke, H Beug.   

Abstract

The v-erbA oncogene, a mutated version of the thyroid hormone receptor alpha (c-erbA/TR-alpha), inhibits erythroid differentiation and constitutively represses transcription of certain erythrocyte genes, suggesting a normal function of the proto-oncogene c-erbA in erythropoiesis. Here we demonstrate that the endogenous thyroid hormone receptor alpha (c-erbA/TR-alpha) and the closely related retinoic acid receptor alpha (RAR-alpha) play a role in the regulation of normal erythroid differentiation. Retinoic acid (RA) distinctly modulated the erythroid differentiation program of normal erythroid progenitors and erythroblasts reversibly transformed by a conditional tyrosine kinase oncogene. When added pulsewise to immature cells, differentiation was accelerated while more mature cells underwent premature cell death. Thyroid hormone (T3) alone caused similar but weaker effects. Interestingly, T3 strongly enhanced the action of RA, suggesting cooperative action of the two receptors in modulating erythroid differentiation. Expression of the human RAR-alpha in receptor-negative erythroblasts conferred RA-induced regulation of differentiation to the otherwise unresponsive cells, thus showing that the RAR-alpha is essential for the RA effect. Likewise, enhanced expression of exogenous c-erbA/TR-alpha in erythroblasts rendered them susceptible to modulation of differentiation by T3, suggesting a similar function of both receptors.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1347914

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  21 in total

1.  Multiple mutations contribute to repression by the v-Erb A oncoprotein.

Authors:  Sangho Lee; Martin L Privalsky
Journal:  Oncogene       Date:  2005-10-13       Impact factor: 9.867

2.  Spi-1/PU.1 transgenic mice develop multistep erythroleukemias.

Authors:  F Moreau-Gachelin; F Wendling; T Molina; N Denis; M Titeux; G Grimber; P Briand; W Vainchenker; A Tavitian
Journal:  Mol Cell Biol       Date:  1996-05       Impact factor: 4.272

3.  Myb-Ets fusion oncoprotein inhibits thyroid hormone receptor/c-ErbA and retinoic acid receptor functions: a novel mechanism of action for leukemogenic transformation by E26 avian retrovirus.

Authors:  A Rascle; N Ferrand; O Gandrillon; J Samarut
Journal:  Mol Cell Biol       Date:  1996-11       Impact factor: 4.272

4.  v-jun cooperates with v-erbB to transform the thrombocytic/megakaryocytic lineage.

Authors:  M Garcia; J Samarut
Journal:  Proc Natl Acad Sci U S A       Date:  1993-10-01       Impact factor: 11.205

5.  The erbA oncogene represses the actions of both retinoid X and retinoid A receptors but does so by distinct mechanisms.

Authors:  H W Chen; M L Privalsky
Journal:  Mol Cell Biol       Date:  1993-10       Impact factor: 4.272

6.  v-erbA acts on retinoic acid receptors in immature avian erythroid cells.

Authors:  S Sande; M Sharif; H Chen; M Privalsky
Journal:  J Virol       Date:  1993-02       Impact factor: 5.103

7.  A conserved C-terminal sequence that is deleted in v-ErbA is essential for the biological activities of c-ErbA (the thyroid hormone receptor).

Authors:  F Saatcioglu; P Bartunek; T Deng; M Zenke; M Karin
Journal:  Mol Cell Biol       Date:  1993-06       Impact factor: 4.272

8.  Nuclear hormone receptors involved in neoplasia: erb A exhibits a novel DNA sequence specificity determined by amino acids outside of the zinc-finger domain.

Authors:  H Chen; Z Smit-McBride; S Lewis; M Sharif; M L Privalsky
Journal:  Mol Cell Biol       Date:  1993-04       Impact factor: 4.272

9.  The thyroid hormone receptor functions as a ligand-operated developmental switch between proliferation and differentiation of erythroid progenitors.

Authors:  A Bauer; W Mikulits; G Lagger; G Stengl; G Brosch; H Beug
Journal:  EMBO J       Date:  1998-08-03       Impact factor: 11.598

10.  Retinoic acid protects human breast cancer cells against etoposide-induced apoptosis by NF-kappaB-dependent but cIAP2-independent mechanisms.

Authors:  Ana M Jiménez-Lara; Ana Aranda; Hinrich Gronemeyer
Journal:  Mol Cancer       Date:  2010-01-26       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.